현재 사용 중인 언어로는 이 페이지를 사용할 수 없습니다. Google Translate을 사용하여
자동 번역된 페이지
를 볼 수 있습니다. Renishaw에게는 이 서비스를 제공할 책임이 없으며 번역 결과를 저희가 확인하지도 않았습니다.
추가로 도움이 필요하시면
저희에게 연락해 주십시오.
neuromate® frameless Gen II robot installation and first deep brain stimulation (DBS) performed in the USA at The Ohio State University Wexner Medical Center
3 August 2015
Renishaw is pleased to announce that a neuromate frameless Gen II stereotactic robotic system has been installed at the Department of Neurological Surgery at The Ohio State University Wexner Medical Center in Columbus, Ohio.
Ali Rezai, MD, Professor of Neurosurgery and Neuroscience and Director, OSU Center for Neuromodulation, is the head of the team who performed the first case in the USA using the neuromate frameless Gen II system for the implantation of DBS electrodes.
Dr. Rezai said, “We believe that robotic technology has an exciting future in the neurosurgery operating rooms for DBS, brain infusion, endoscopy and other applications. Based on our very first robotic DBS procedure we see procedural and time saving advantages.”
Dr. Abed Hammoud, CEO of Renishaw Mayfield SA said, “We are very proud to have Dr. Rezai and his team among our partners, and will work closely with them to ensure the seamless integration of the neuromate into their workflow.”
For further information on neuromate, visit www.renishaw.com/neuromate
Downloads
For more images, videos or information on Renishaw and its products, visit our mediahub